Zentalis Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7k | 110 | 15.15 |
| 2023-09-30 | $1.3M | 67k | 20.06 |
| 2023-06-30 | $2.5M | 90k | 28.24 |
| 2023-03-31 | $1.4M | 83k | 17.20 |
| 2022-12-31 | $3.1M | 155k | 20.13 |
| 2022-09-30 | $1.0M | 25k | 41.67 |
| 2022-06-30 | $839k | 30k | 28.11 |
| 2022-03-31 | $3.4M | 74k | 46.17 |
| 2021-12-31 | $3.0M | 36k | 83.98 |
| 2021-09-30 | $18k | 265 | 67.92 |
| 2021-06-30 | $14k | 255 | 54.90 |
| 2020-12-31 | $9.0k | 182 | 49.45 |
| 2020-06-30 | $12k | 257 | 46.69 |